BSPM [Biostar Pharmaceuticals,] 8-K: Chairman and CEO of Biostar Pharmaceuticals, Inc. Adopts

[Chairman and CEO of Biostar Pharmaceuticals, Inc. Adopts 10b5-1 Share Repurchase Plan Rule 10b5-1 permits corporate officers, directors and others to adopt written, pre-arranged stock trading plans when they are not in possession of material, non-public information. These plans allow insiders to have shares bought or sold for their accounts over a period of time regardless of any material, non-public]

By | 2016-03-03T12:46:25+00:00 May 25th, 2011|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

UTSI [UTSTARCOMS] 425: (Original Filing)

[Under the Securities Act of 1933 Subject Company: UTStarcom, Inc. Commission File No.: 333-173828 UTStarcom Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for Its 2011 Annual Meeting of Stockholders UTStarcom will commence the mailing of the proxy statement/prospectus to all holders of UTStarcom common stock as of the record date on May 25, 2011. The proposed]

By | 2016-03-01T13:28:59+00:00 May 25th, 2011|Categories: Chinese Stocks, SEC Original, UTSI|Tags: , , , , , |0 Comments

UTSI [UTSTARCOMS] 425: Under the Securities Act of 1933 Subject Company:

[Under the Securities Act of 1933 Subject Company: UTStarcom, Inc. Commission File No.: 333-173828 UTStarcom Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for Its 2011 Annual Meeting of Stockholders UTStarcom will commence the mailing of the proxy statement/prospectus to all holders of UTStarcom common stock as of the record date on May 25, 2011. The proposed]

By | 2016-03-01T13:29:34+00:00 May 25th, 2011|Categories: Chinese Stocks, UTSI, Webplus ver|Tags: , , , , , |0 Comments

UTSI [UTSTARCOMS] DEF 14A: (Original Filing)

[ý No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: o Fee paid previously with preliminary materials. o Check box if]

By | 2016-03-01T13:30:49+00:00 May 25th, 2011|Categories: Chinese Stocks, SEC Original, UTSI|Tags: , , , , , |0 Comments

UTSI [UTSTARCOMS] DEF 14A: ý No fee required. o Fee computed on

[ý No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: o Fee paid previously with preliminary materials. o Check box if]

By | 2016-03-01T13:31:29+00:00 May 25th, 2011|Categories: Chinese Stocks, UTSI, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Chairman and CEO of Biostar Pharmaceuticals, Inc. Adopts 10b5-1 Share Repurchase Plan Rule 10b5-1 permits corporate officers, directors and others to adopt written, pre-arranged stock trading plans when they are not in possession of material, non-public information. These plans allow insiders to have shares bought or sold for their accounts over a period of time regardless of any material, non-public]

By | 2016-03-03T12:45:16+00:00 May 25th, 2011|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

UTSI [UTSTARCOMSRP.] 425: (Original Filing)

[Under the Securities Act of 1933 Subjectmpany: UTStarcom,Inc.mmission File No.: 333-173828 UTStarcom Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for Its 2011 Annual Meeting of Stockholders UTStarcom willmmence the mailing of the proxy statement/prospectus tol holders of UTStarcommmon stock of the recordte on May25, 2011.]

By | 2016-02-05T09:44:51+00:00 May 25th, 2011|Categories: Chinese Stocks, SEC Original, UTSI|Tags: , , , , , |0 Comments

CISG [CNINSURE] 6-K: IR-119 CNinsure Reports First Quarter 2011 Unaudited Financial

[IR-119 CNinsure Reports First Quarter 2011 Unaudited Financial Results — Quarterly Basic and Diluted EPS from Continuing Operations up 21.3% and 22.6% CISG 1 GUANGZHOU, May 23, 2011 (GLOBE NEWSWIRE) — CNinsure Inc., (Nasdaq: Financial Highlight: Highlights for First Quarter 2011 • Total net revenues: RMB313.7 million (US$47.9 million), representing an increase of 28.3% from the corresponding period of 2010.] [FORM 6-K CNINSURE INC. 22/F, Yinhai Building þ o Form 20-F o o CNinsure Inc. Peng Ge Chief Financial Officer 6-K 1 c17866e6vk.htm FORM 6-K]

Skip to toolbar